Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.720
-0.060 (-1.26%)
May 29, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 17 or -42.50% compared to the previous year.
Employees
23
Change
-17
Growth
-42.50%
Revenue / Employee
n/a
Profits / Employee
-$5,035,043
Market Cap
233.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -17 | -42.50% |
| Sep 30, 2025 | 22 | -31 | -58.49% |
| Jun 30, 2025 | 21 | -49 | -70.00% |
| Mar 31, 2025 | 18 | -57 | -76.00% |
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Sep 30, 2024 | 53 | -35 | -39.77% |
| Jun 30, 2024 | 70 | -19 | -21.35% |
| Mar 31, 2024 | 75 | -5 | -6.25% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Sep 30, 2023 | 88 | 12 | 15.79% |
| Jun 30, 2023 | 89 | 22 | 32.84% |
| Mar 31, 2023 | 80 | 26 | 48.15% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Sep 30, 2022 | 76 | 55 | 261.90% |
| Jun 30, 2022 | 67 | 57 | 570.00% |
| Mar 31, 2022 | 54 | 44 | 440.00% |
| Dec 31, 2021 | 39 | 31 | 387.50% |
| Sep 30, 2021 | 21 | 13 | 162.50% |
| Mar 31, 2021 | 10 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| Alector | 103 |
| Caribou Biosciences | 97 |
| Orchestra BioMed Holdings | 86 |
| Cybin | 50 |
| Camp4 Therapeutics | 48 |
WHWK News
- 1 day ago - Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 - PRNewsWire
- 2 days ago - Whitehawk Therapeutics Registration statement: Registration filing - Filings
- 3 days ago - Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference - PRNewsWire
- 4 days ago - Whitehawk Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 10 days ago - Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload - PRNewsWire
- 11 days ago - Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit - PRNewsWire
- 12 days ago - Whitehawk Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 16 days ago - Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum - PRNewsWire